Clinical Trials Browser

Phase 1 × Pharmacogenomic Variants × 90 days × Clear all

NCT05627245 2026-03-18

Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment

Phase 1 Active not recruiting

DermatologicLymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous

NCT01165333 2026-03-16

CILENT

Phase 1 Completed

Diffuse Intrinsic Pontine Glioma, Glioma